Rare diseases
Investigational molecules
Locations
Back to Germany1 444 clinical trials in Hochheim Am Main, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on Quemliclustat and Chemotherapy for Patients with Metastatic Pancreatic Cancer
GermanyStudy on the Effects of Povorcitinib for Patients with Prurigo Nodularis
GermanyStudy on the Safety and Effectiveness of Opelconazole with Other Antifungal Treatments for Patients with Hard-to-Treat Lung Aspergillosis
GermanyStudy of tozorakimab effectiveness and safety in former smokers with Chronic Obstructive Pulmonary Disease (COPD) who experience disease flare-ups
GermanyStudy Comparing ABP 206 and Nivolumab for Patients with Unresectable or Metastatic Melanoma
GermanyStudy on FX06 for Improving Acute Respiratory Distress Syndrome in Patients
GermanyStudy on the Safety and Effectiveness of Osimertinib and Datopotamab Deruxtecan for Patients with Advanced EGFR Mutation-Positive Non-Small Cell Lung Cancer
GermanyStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Ulcerative Colitis
GermanyStudy on Batoclimab for Treating Patients with Active Thyroid Eye Disease
GermanyStudy on ANV600 and Pembrolizumab for Patients with Advanced Solid Tumors
GermanyStudy of Resmetirom in Patients with Well-compensated Non-alcoholic Steatohepatitis (NASH) Cirrhosis to Evaluate Effects on Liver Health
GermanyStudy on Palbociclib and Endocrine Therapy for Patients with HR+/HER2- Early Breast Cancer
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Gaucher disease and Niemann-Pick disease, exploring new therapeutic approaches for these challenging genetic conditions. Studies aim to evaluate novel treatments for improving neurological symptoms and overall patient outcomes.
Clinical investigations evaluating venglustat and nizubaglustat's effectiveness in managing disease progression.
Research centered on treating Mucopolysaccharidosis Type II (Hunter Syndrome) and Pompe disease, with multiple studies investigating innovative enzyme replacement therapies and novel drug combinations.
Evaluation of treatments like JR-141 and cipaglucosidase alfa for improved patient outcomes.
Studies focused on preventing respiratory syncytial virus infections in older adults, with particular attention to vaccine development and immune response assessment.
Investigation of revaccination strategies and long-term protection against respiratory infections.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
